Effects of an extracellular metal chelator on neurovascular function in diabetic rats

Diabetologia

Volumn 44, Issue 5, 2001, Pages 621-628

  Cameron, N E ^a   Cotter, M A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Blood flow; Chelator; Copper; Deferoxamine; Diabetic rat; Iron; Nerve conduction; Neuropathy; Oxidative stress

Indexed keywords

ANTIOXIDANT; DEFEROXAMINE; FREE RADICAL; HETASTARCH; HYDROGEN; METAL CHELATE; STREPTOZOCIN;

ADULT; ARTICLE; BLOOD FLOW; CATALYSIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MOTOR NERVE CONDUCTION; OXIDATIVE STRESS; PERFUSION; POLAROGRAPHY; PRIORITY JOURNAL; SCIATIC NERVE; VASCULAR DISEASE; VELOCITY;

ANIMALS; BLOOD GLUCOSE; DEFEROXAMINE; DIABETES MELLITUS, EXPERIMENTAL; HETASTARCH; IRON CHELATING AGENTS; MALE; MOTOR NEURONS; NEURAL CONDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REGIONAL BLOOD FLOW; SCIATIC NERVE; TIME FACTORS;

EID: 0035022306     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051669     Document Type: Article

References (57)

1. Oxygen free radical effects in sciatic nerve in experimental diabetes
2. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes
3. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy
4. Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction
5. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta
6. Contraction and relaxation of aortas from diabetic rats: Effects of chronic anti-oxidant and aminoguanidine treatments
7. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: Influence of tocopherol as antioxidant
8. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats
9. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats
10. Effects of the sulphydryl donor N-acetyl-1-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats
11. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with n-acetylcysteine
12. Nerve function and regeneration in diabetic and galactosaemic rats: Anti-oxidant and metal chelator effects
13. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats
14. Diabetes mellitus and free radicals
15. Altered tissue content and cytosol distribution of trace metals in experimental diabetes
16. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus
17. Neurovascular deficits in diabetic rats: Potential contribution of autoxidation and free radicals examined using transition metal chelating agents
18. Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats
19. Diabetes-induced endothelial dysfunction is prevented by long term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine
20. 1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
21. New therapeutic approaches to prevent or halt the progression of the long-term complications of diabetes mellitus: Focus on neuropathy
22. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers
23. Polymer conjugation reduces deferoxamine induced retinopathy in an albino rat model
24. Protective effects of hydroxyethyl starch-deferoxamine in early sepsis
25. Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation
26. Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis
27. The long-acting parenteral iron chelator, hydroxyethyl starch-deferoxamine, fails to protect against alcohol-induced liver injury in rats
28. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats
29. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats
30. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats
31. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy
32. Antioxidants in the treatment of diabetic polyneuropathy: Synergy with essential fatty acids
33. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes
34. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
35. Formation of glyoxal, methylglyoxal, and 3-deoxyglucasone in the glycation of protein by glucose
36. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
37. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction
38. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes
39. Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications
40. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: Relevance to diseases of glycoxidative stress
41. 2+
42. Effects of α-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids
43. Rapid reversal by amino-guanidine of the neurovascular effects of diabetes in rats: Modulation by nitric oxide synthase inhibition
44. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism
45. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy
46. Effects of diabetes on reactivity of sciatic vasa nervorum in rats
47. Rapid reversal of a motor nerve conduction deficit in streptozotocin-diabetic rats by the angiotensin converting enzyme inhibitor lisinopril
48. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates angiogenesis in streptozotocin-diabetic rats
49. Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats
50. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat
51. Pathology and pathogenetic mechanisms of diabetic neuropathy
52. Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: Potential clamp analysis
53. Potential clamp analysis of the effect of anoxia on the nodal function of rat peripheral nerve fibres
54. A note on the mechanism of resistance to anoxia and ischaemia in the pathophysiological mammalian myelinated nerve
55. Vascular factors in diabetic neuropathy
56. Minalrestat
57. Oxidative stress and Na/K ATPase activity in diabetic rats: Aldose reductase inhibitor withdrawal studies